Arkolith/Insider Trading/MYMD/Form 4

Silverman Joshua

DirectorMyMD Pharmaceuticals, Inc. (MYMD) · full profile →Form 4 · filed Nov 29, 2021
Net Buying
Open-Market Buys
$103K
Open-Market Sells
$0
Net Open-Market Flow
$103K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 26, 2021Buy(P)5K$7.55$38K89K
Nov 24, 2021Buy(P)3K$7.09$23K84K
Nov 24, 2021Buy(P)7K$6.30$42K81K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-21-029973) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML